Technical Analysis for ALDX - Aldeyra Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.71 -5.42% -0.27
ALDX closed down 5.42 percent on Friday, August 23, 2019, on 47 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ALDX trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -5.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -7.83%
Up 3 Days in a Row Strength -7.83%

Older signals for ALDX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aldeyra Therapeutics, Inc. (Aldeyra) is a biotechnology company. The Company is focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The Company is developing NS2. NS2 is a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of diseases, which include Sjogren-Larsson Syndrome (SLS), discoid lupus, acute anterior uveitis and ocular rosacea with meibomian gland dysfunction. Aldeyra is also developing aldehyde traps distinct from NS2. As of April 7, 2014, it had evaluated NS2 in a Phase I clinical trial in 48 volunteers.
Medicine Biotechnology Medical Specialties Diseases Organ Systems Autoimmune Diseases Rare Diseases Uveitis Inflammatory Syndromes
Is ALDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.7
52 Week Low 4.64
Average Volume 259,646
200-Day Moving Average 7.6992
50-Day Moving Average 5.7053
20-Day Moving Average 5.213
10-Day Moving Average 5.057
Average True Range 0.3044
ADX 22.77
+DI 16.7183
-DI 27.3602
Chandelier Exit (Long, 3 ATRs ) 5.0868
Chandelier Exit (Short, 3 ATRs ) 5.5532
Upper Bollinger Band 5.6644
Lower Bollinger Band 4.7616
Percent B (%b) -0.06
BandWidth 17.318243
MACD Line -0.2203
MACD Signal Line -0.2137
MACD Histogram -0.0066
Fundamentals Value
Market Cap 29.42 Million
Num Shares 6.25 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -3.20
Price-to-Sales 0.00
Price-to-Book 4.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.43
Resistance 3 (R3) 5.49 5.30 5.31
Resistance 2 (R2) 5.30 5.12 5.28 5.27
Resistance 1 (R1) 5.01 5.01 4.92 4.95 5.23
Pivot Point 4.82 4.82 4.78 4.80 4.82
Support 1 (S1) 4.53 4.64 4.44 4.47 4.19
Support 2 (S2) 4.34 4.53 4.32 4.15
Support 3 (S3) 4.05 4.34 4.11
Support 4 (S4) 3.99